Clinical Trial Update: Kuvan in People With Schizophrenia and Schizoaffective Disorder [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Kuvan investigating schizophrenia and schizoaffective disorder across Phase 1 and Phase 2, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-09-13